Vaginal Hysterectomy in India
Get Vaginal Hysterectomy at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Vaginal Hysterectomy in UAE
Vaginal Hysterectomy at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Vaginal hysterectomy is a minimally invasive surgical procedure to remove the uterus through the vaginal canal, avoiding abdominal incisions and offering faster recovery, reduced post-operative pain, and shorter hospital stays compared to open abdominal hysterectomy. The procedure carries a clinical success rate exceeding 95% for appropriately selected patients, with outcomes comparable to the world's leading gynecological centres. GAF Healthcare connects international patients with JCI- and NABH-accredited hospitals in India and JCI- and DHA-accredited facilities in the UAE, delivering expert surgical care at a fraction of Western costs, with end-to-end medical travel coordination.
Hospital Stay: 2–4 days • Total Stay in Country (Fit-to-Fly): 3–4 weeks • Success Rate: 95–98%
What Is It?
The uterus is a hormone-responsive, muscular pelvic organ whose pathological changes — including symptomatic uterine fibroids, adenomyosis, uterine prolapse, endometrial hyperplasia, chronic pelvic pain, and early-stage gynecological malignancies — can profoundly impair a woman's quality of life, fertility intentions, urinary continence, and overall pelvic floor integrity. When medical management (hormonal therapy, levonorgestrel-releasing intrauterine systems, GnRH agonists such as leuprolide acetate, or uterine artery embolisation) fails or is contraindicated, surgical removal of the uterus — hysterectomy — remains the definitive treatment. Globally, hysterectomy is one of the most commonly performed major gynaecological surgeries, and the vaginal route is endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the Royal College of Obstetricians and Gynaecologists (RCOG) as the preferred approach when anatomically feasible, owing to its superior safety profile and recovery advantages.
Vaginal hysterectomy (VH) is performed entirely through the vaginal introitus, requiring no external skin incisions. The surgeon divides and ligates the uterine ligaments (cardinal, uterosacral, broad, and round ligaments) and uterine vessels under direct vision or with laparoscopic assistance, then delivers the uterus vaginally. When combined with laparoscopic guidance — termed laparoscopically assisted vaginal hysterectomy (LAVH) or total laparoscopic hysterectomy with vaginal extraction — the surgeon gains panoramic pelvic visualisation using a 0° or 30° laparoscope and advanced energy devices (LigaSure™, Harmonic Scalpel™), enabling safe management of adhesions, endometriosis, or adnexal pathology before completing the vaginal extraction. Concomitant procedures such as anterior colporrhaphy, posterior colporrhaphy, McCall culdoplasty, or sacrospinous ligament fixation for pelvic organ prolapse repair are routinely performed during the same anaesthetic.
The standard of care for vaginal hysterectomy in both India and the UAE has advanced considerably over the past decade. Leading tertiary hospitals now use 3D high-definition laparoscopic cameras, articulating instruments, and vessel-sealing energy platforms that significantly reduce intraoperative blood loss (mean estimated blood loss under 150 mL in expert hands). Enhanced Recovery After Surgery (ERAS) protocols — including carbohydrate loading, multimodal analgesia with NSAIDs and acetaminophen, opioid-sparing strategies, early ambulation, and same-day oral feeding — are standard practice, enabling many patients to be discharged within 48 hours. Intraoperative cystoscopy is routinely performed to confirm ureteral and bladder integrity, reducing the risk of unrecognised urinary tract injury.
Candidates
ELIGIBLE CANDIDATES:
• Women with symptomatic uterine fibroids (leiomyomas) unresponsive to medical therapy, with uterine size ≤12–14 weeks gestation (relative guide)
• Adenomyosis causing menorrhagia, dysmenorrhoea, or chronic pelvic pain refractory to hormonal management
• Uterine prolapse (Stage II–IV per POP-Q classification), particularly when concurrent pelvic floor repair is planned
• Endometrial hyperplasia with atypia or low-grade endometrial carcinoma (FIGO Stage IA) where vaginal approach is feasible
• Dysfunctional uterine bleeding uncontrolled by endometrial ablation, Mirena IUS, or hormonal therapy
• Chronic pelvic pain with confirmed uterine pathology (e.g., diffuse adenomyosis on MRI)
• Women who have completed childbearing and give informed consent for permanent loss of fertility
• Adequate vaginal capacity and uterine mobility on bimanual pelvic examination
REQUIRED PRE-OPERATIVE DIAGNOSTICS:
• Transvaginal ultrasound (TVUS) — uterine size, fibroid mapping, endometrial thickness
• Pelvic MRI — adenomyosis extent, fibroid location (submucosal, intramural, subserosal), adnexal assessment
• Endometrial biopsy (Pipelle or hysteroscopic-directed) — histological exclusion of malignancy
• Cervical smear (Pap test / LBC) — exclusion of cervical dysplasia or carcinoma
• Complete blood count (CBC) — haemoglobin status; iron deficiency anaemia correction pre-operatively
• Coagulation profile (PT, aPTT, INR)
• Renal and hepatic function panel
• HbA1c (if diabetic), thyroid function tests (as clinically indicated)
• Urodynamic studies — if concurrent stress urinary incontinence or prolapse repair is planned
• Chest X-ray and 12-lead ECG — standard anaesthetic pre-assessment
• Cardiology clearance (ECHO if indicated) — for patients with known cardiac disease
• CA-125 — if adnexal pathology or endometriosis is suspected
CONTRAINDICATIONS:
• Uterine size >16–18 weeks gestation (unless morcellation or bisection technique is planned by experienced surgeon)
• Severe obliteration of the cul-de-sac (dense posterior pelvic adhesions from prior surgery, severe endometriosis Stage IV — may require laparoscopic conversion)
• Suspected or confirmed advanced gynaecological malignancy requiring staging lymphadenectomy (abdominal or robotic approach preferred)
• Significant extrauterine pelvic disease requiring extensive adhesiolysis beyond vaginal access
• Active pelvic infection (surgery deferred until treated)
• Uncontrolled systemic coagulopathy
• Patient unwilling to accept loss of fertility or uterus
Procedure
SURGICAL APPROACHES TO HYSTERECTOMY — COMPARATIVE OVERVIEW:
1. TRADITIONAL VAGINAL HYSTERECTOMY (TVH) The gold-standard vaginal approach involves a circumferential colpotomy incision at the cervicovaginal junction, sequential clamping, cutting, and suture ligation of the uterosacral and cardinal ligaments (parametria), uterine arteries, and upper pedicles (round ligament, fallopian tube, ovarian ligament). The uterus is delivered in toto or, if enlarged, by surgical debulking using intramyometrial coring, bisection (Heaney technique), or wedge morcellation — all performed vaginally. The vaginal vault is closed with absorbable sutures (polyglactin 910 or barbed suture), and McCall culdoplasty or uterosacral ligament suspension is performed to prevent future vault prolapse. Advantages: no abdominal incisions, lowest complication rate in suitable patients, cost-effective.
2. LAPAROSCOPICALLY ASSISTED VAGINAL HYSTERECTOMY (LAVH) Laparoscopic ports (typically one 10 mm umbilical and two 5 mm lateral trocars) allow the surgeon to use CO2 pneumoperitoneum to inspect the pelvis, lyse adhesions, treat endometriosis implants, and divide the adnexa and upper uterine pedicles using advanced energy devices (LigaSure™ vessel sealing system, Harmonic Ace+7™ ultrasonic shears). The remainder of the procedure is completed vaginally. LAVH is preferred when adnexal pathology, adhesions from prior caesarean sections, or mild-to-moderate endometriosis is present. Blood loss and conversion rates are significantly reduced.
3. TOTAL LAPAROSCOPIC HYSTERECTOMY WITH VAGINAL EXTRACTION (TLH) The entire procedure — including uterine artery coagulation, colpotomy, and pedicle division — is performed laparoscopically using 3D high-definition (HD) or 4K camera systems and articulating instruments. The uterus is extracted vaginally after complete laparoscopic dissection. Robotic-assisted TLH using the da Vinci Xi or da Vinci SP surgical systems provides 7-degree-of-freedom wristed instrument motion, superior ergonomics, and enhanced visualisation in narrow pelvises or after prior pelvic surgery. This is particularly advantageous in patients with BMI >35, prior multiple abdominal surgeries, or complex endometriosis.
4. VAGINAL NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY (vNOTES) vNOTES is an emerging, scar-free technique in which a purpose-designed access port (GelPOINT V-Path) is inserted transvaginally, and the entire procedure is performed endoscopically through the vaginal orifice. Available at select advanced centres in India and the UAE, vNOTES offers equivalent clinical outcomes to laparoscopic hysterectomy with no visible scars, reduced analgesic requirements, and potential for same-day discharge. Evidence from multicentre RCTs (including the HALON and MUSA trials) supports its safety and efficacy.
5. CONCURRENT PELVIC FLOOR PROCEDURES When vaginal hysterectomy is performed for uterine prolapse, concomitant procedures routinely include: anterior colporrhaphy (anterior vaginal wall repair for cystocoele), posterior colporrhaphy with levator ani plication (for rectocoele), sacrospinous ligament fixation (Nichols technique) or iliococcygeus suspension for apical support, and tension-free vaginal tape (TVT) or transobturator tape (TOT) for concurrent stress urinary incontinence.
6. ANAESTHESIA Spinal anaesthesia (with or without epidural for post-operative analgesia) is the preferred anaesthetic modality for vaginal hysterectomy, reducing nausea, systemic opioid requirements, and post-operative ileus. General anaesthesia with laryngeal mask airway (LMA) or endotracheal intubation is used when spinal anaesthesia is contraindicated or patient preference dictates.
Cost of Vaginal Hysterectomy: India vs. UAE
The cost of vaginal hysterectomy varies significantly depending on the surgical approach (traditional vaginal, LAVH, TLH, robotic, or vNOTES), hospital tier (private versus public, standard versus luxury suite), anaesthesia type, duration of hospitalisation, inclusion of concomitant procedures (e.g., pelvic floor repair), and implant or mesh usage. India offers world-class gynaecological surgery at costs that are 50–65% lower than comparable procedures in the UAE, making it the preferred destination for cost-conscious international patients. The UAE, particularly Dubai and Abu Dhabi, provides a premium healthcare environment with ultra-modern hospital infrastructure, multilingual clinical teams, and minimal visa formalities — ideal for GCC-region patients or those prioritising shorter travel distances. Both destinations offer JCI-accredited hospitals with internationally trained gynaecological surgeons, many of whom hold fellowships from the UK, USA, or Australia.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $2,000 – $5,000 | ~59% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $5,000 – $12,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PRE-OPERATIVE PHASE (4–6 weeks before surgery):
• Remote consultation with GAF Healthcare's partner gynaecologist: review of medical records, imaging (MRI/TVUS), biopsy reports, and surgical planning
• Pre-operative optimisation: iron therapy for anaemia (IV iron sucrose infusion if haemoglobin <10 g/dL), GnRH agonist (depot leuprolide 3.75 mg IM) may be prescribed 4–8 weeks pre-operatively to reduce fibroid volume and control bleeding
• Travel and visa documentation coordinated by GAF Healthcare case manager
• Arrival in India or UAE: 2–3 days before surgery for in-person pre-operative assessment, anaesthesia review, repeat blood work, and consent
• Bowel preparation: mechanical bowel preparation is generally NOT required under modern ERAS protocols; a light diet and overnight fast suffice
• Antibiotic prophylaxis: IV Cefazolin 2g (or Clindamycin if penicillin-allergic) administered 30–60 minutes before incision
• DVT prophylaxis: low-molecular-weight heparin (enoxaparin 40 mg SC) commenced pre-operatively and continued post-operatively; graduated compression stockings applied
INTRAOPERATIVE PHASE (Duration: 60–180 minutes depending on approach and complexity):
• Patient positioned in the dorsal lithotomy position with Allen stirrups; careful padding of pressure points
• Spinal or general anaesthesia administered
• Urinary catheter inserted (Foley catheter, 14–16 Fr)
• Vaginal preparation with chlorhexidine gluconate solution
• For LAVH/TLH: laparoscopic ports inserted; pneumoperitoneum established at 10–12 mmHg CO2; pelvic inspection performed; adnexa managed; adhesiolysis if required
• Circumferential colpotomy performed; sequential ligation of uterosacral, cardinal, uterine, and upper pedicles
• Uterus delivered vaginally (with debulking if necessary)
• Vault closure with absorbable suture; McCall culdoplasty or vault suspension sutures placed
• Intraoperative cystoscopy performed to confirm bilateral ureteric jets and bladder integrity
• Concomitant pelvic floor repair completed if planned
• Intraoperative IV tranexamic acid 1g administered to minimise blood loss
IMMEDIATE POST-OPERATIVE PHASE (Day 0–2):
• Recovery room: haemodynamic monitoring, pain assessment, early resumption of oral fluids within 2–4 hours
• Multimodal analgesia: scheduled paracetamol 1g QID + ibuprofen 400 mg TDS + low-dose opioid (tramadol or morphine PCA) for breakthrough pain
• Urinary catheter removal at 24 hours; trial of void confirmed
• Early ambulation: patient encouraged to sit and walk with assistance from post-operative evening (Day 0) or morning of Day 1
• Diet: light solid food reintroduced by Day 1 in line with ERAS protocol
• Hospital discharge: typically Day 2–4 depending on procedure complexity and recovery
EARLY RECOVERY (Weeks 1–3 — Remaining in India/UAE):
• Outpatient wound/vault check at Day 7 post-operatively
• Pelvic rest: no vaginal intercourse, no tampons, no swimming for minimum 6 weeks
• Physical activity: short walks encouraged from Day 3; avoid lifting >5 kg, strenuous exercise, or prolonged sitting for 2–3 weeks
• Vaginal discharge (pink-brown) is expected for 2–4 weeks as vault sutures dissolve
• Hot showers permitted from Day 2; bath or swimming prohibited until vault healed (6 weeks)
• Hormone replacement therapy (HRT) if bilateral salpingo-oophorectomy was performed: transdermal oestradiol patch (Estradot 50 mcg twice weekly) commenced from Day 1 post-operatively
• DVT prophylaxis (enoxaparin) continued for 28 days post-operatively in high-risk patients (BMI >30, history of VTE, malignancy)
• Fit-to-fly assessment at Week 3: clinical review, confirmation of vault healing, no signs of infection or haematoma
FIT TO FLY: International flight is generally safe at 3–4 weeks post-operatively for uncomplicated vaginal hysterectomy. Extended laparoscopic or robotic cases, or those with complications, may require 4–6 weeks. Compression stockings and ambulation every 1–2 hours during the flight are strongly advised. Enoxaparin on the day of travel is recommended for high-risk patients.
FULL RECOVERY MILESTONES:
• Return to sedentary work: 3–4 weeks
• Return to driving: 4–6 weeks (when able to perform emergency stop)
• Return to exercise/gym: 6–8 weeks
• Sexual intercourse: 6–8 weeks (vault fully healed)
• Full physiological recovery: 3–6 months
• Follow-up gynaecology review: 6 weeks, 3 months, 12 months post-operatively
Risks & Considerations
Vaginal hysterectomy is a major surgical procedure with an excellent safety profile in experienced hands, but patients must be counselled about specific risks prior to surgery. Intraoperative risks include haemorrhage requiring blood transfusion (incidence approximately 1–3%), inadvertent injury to adjacent pelvic structures — particularly the urinary bladder (0.5–1%), ureters (0.1–0.3%), or rectum (<0.5%) — and anaesthetic complications including deep vein thrombosis (DVT) or pulmonary embolism (PE), which is mitigated by aggressive pharmacological (LMWH) and mechanical (compression stockings, pneumatic sequential compression devices) prophylaxis. Post-operative risks include vaginal vault haematoma or infection (1–2%), urinary tract infection (5–10%), urinary retention requiring temporary recatheterisation, and delayed vault dehiscence (rare, <1%). Conversion to abdominal or laparoscopic hysterectomy occurs in fewer than 3% of planned vaginal cases at high-volume centres. Long-term considerations include pelvic floor dysfunction, dyspareunia (pain with intercourse) occurring in approximately 5–10% of patients (often transient), and vault prolapse over subsequent years if vault suspension was not performed. If bilateral oophorectomy is performed concurrently (removal of ovaries), surgically induced menopause begins immediately — resulting in vasomotor symptoms, urogenital atrophy, accelerated bone mineral loss, and cardiovascular risk changes — for which systemic HRT or alternative therapies should be proactively prescribed. Patients with obesity (BMI >35), prior pelvic radiation, previous multiple abdominal or pelvic surgeries, or known coagulopathies face elevated surgical risk and should undergo pre-operative risk stratification using validated tools such as the ASA Physical Status Classification and surgical risk calculators (e.g., ACS-NSQIP Surgical Risk Calculator). GAF Healthcare ensures all partner hospitals conduct a thorough pre-operative multidisciplinary review for high-risk patients.
Top Hospitals for Vaginal Hysterectomy
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
Manipal Hospitals Dwarka
New Delhi, India
Burjeel Hospital for Advanced Surgery Dubai
Dubai, UAE
Kings College Hospital Dubai
Dubai, UAE
Aster Hospital Dubai
Dubai, UAE
Top Doctors for Vaginal Hysterectomy
Internationally trained specialists in Gynecology. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Tarang Preet Kaur
MBBS, MS, MRCOG, MCh, Fellowship in Urogynaecology, Fellowship in Cosmetic Gynaecology
Urogynaecologist
Max Super Speciality Hospital, Saket, New Delhi, India
11+ Yearsof experience
Dr. Tarang Preet Kaur is a Consultant in Urogynaecology with over 11 years of clinical experience, currently practicing at Max Super Speciality Hospital, Saket in New Delhi. She holds an MCh in Urogynaecology from Edge Hill University, United Kingdom (2024), the MRCOG from the Royal College of Obstetricians & Gynaecologists, and an MS in Obstetrics & Gynaecology from Maulana Azad Medical College, Delhi. Her dual qualification across India and the UK… Read more
Dr. Amrinder Kaur Bajaj
MBBS, MD — Obstetrics & Gynaecology (Gold Medalist), Senior Residency — Obstetrics & Gynaecology, FRSH — Fellow of the Royal Society of Health, FIAMS — Fellow of the Indian Association of Medical Specialists
Obstetrician & Gynaecologist
Fortis Hospital, Gurgaon, Gurgaon, India
42+ Yearsof experience
Dr. Amrinder Kaur Bajaj is one of Delhi-NCR's most experienced gynaecologists, with over four decades spent caring for women at every stage of life. She currently practises as a Consultant in Obstetrics & Gynaecology at Fortis Hospital, Gurgaon, where she brings together deep clinical knowledge and a quietly reassuring bedside manner that patients — and their families — find genuinely comforting. Her academic journey set a high bar early on. She completed… Read more
Dr. Anuradha Khurana
MBBS, DGO (Diploma in Obstetrics & Gynaecology), PG in High Risk Pregnancy and Infertility
Gynecologist & Obstetrics Specialist
Artemis Hospital, New Delhi, India
20+ Yearsof experience
Dr. Anuradha Khurana is a Senior Consultant in Obstetrics and Gynecology at Artemis Hospital, Delhi, with over two decades of hands-on experience in women's health. She is particularly well regarded for her work in high-risk pregnancy management, uterine conditions like fibroids and endometriosis, and complex gynecological surgeries. Patients and families consistently describe her as someone who takes the time to truly listen — and to explain things in a… Read more
Dr. Aswari Kesari Kapoor
MBBS, DGO (Diploma in Gynaecology & Obstetrics), CPS (College of Physicians and Surgeons), DNB (Diplomate of National Board) — Obstetrics & Gynaecology
Obstetrician & Gynecologist
Indraprastha Apollo Hospital, New Delhi, India
23+ Yearsof experience
Dr. Aswari Kesari Kapoor is a seasoned Obstetrician and Gynecologist with over 23 years of hands-on clinical experience. She practices at Indraprastha Apollo Hospital in New Delhi — one of India's most respected multi-specialty institutions. Over the course of her career, she has built a strong reputation for managing complex gynecological conditions alongside high-risk pregnancies, all with a calm and reassuring bedside manner that patients consistently… Read more
Dr. Bindhu K S
MBBS, DNB (Obstetrics & Gynecology), Fellowship in Minimal Access Surgery, FICOG (Fellowship of the Indian College of Obstetricians and Gynaecologists), Certificate in Gynecologic and Obstetric Sonography, Certificate in Appreciation of Well Being in Fetal Heart Disease
Obstetrician & Gynecologist
Apollo Hospitals, Navi Mumbai, Mumbai, India
23+ Yearsof experience
Dr. Bindhu K S is a seasoned Obstetrician and Gynecologist based in Mumbai, currently practicing at Apollo Hospitals, Navi Mumbai. With over two decades of clinical experience, she brings together expertise in both obstetrics and advanced minimally invasive gynecologic surgery. Whether a patient comes with a complex fibroid, troublesome endometriosis, or a high-risk pregnancy, Dr. Bindhu approaches each situation with careful thought and genuine care. Her… Read more
Frequently Asked Questions — Vaginal Hysterectomy
The total cost of vaginal hysterectomy in India ranges from approximately USD 2,000 to USD 5,000 for a complete package including the surgical procedure, anaesthesia, 2–4 nights hospitalisation, standard post-operative medications, and routine follow-up consultations at a NABH- or JCI-accredited private hospital. The cost varies depending on the surgical approach selected: a traditional vaginal hysterectomy is at the lower end of this range, while a laparoscopically assisted vaginal hysterectomy (LAVH), total laparoscopic hysterectomy (TLH), or robotic-assisted procedure will be toward the higher end, and vNOTES (if available) may attract a premium for specialised instrumentation. In the UAE (Dubai or Abu Dhabi), the equivalent procedure at a JCI- and DHA-accredited hospital costs between USD 5,000 and USD 12,000 — reflecting higher hospital infrastructure costs, premium private room standards, and UAE-level professional fees. In both destinations, costs for concomitant procedures (e.g., anterior or posterior colporrhaphy for prolapse repair, sacrospinous ligament fixation, or TVT sling for urinary incontinence) will be added separately. GAF Healthcare provides transparent, itemised cost estimates specific to each patient's clinical needs before any commitment is made, ensuring there are no hidden charges.
For an uncomplicated vaginal hysterectomy — including traditional vaginal, laparoscopically assisted vaginal (LAVH), or total laparoscopic hysterectomy (TLH) — patients are generally considered medically fit for an international flight at 3–4 weeks post-operatively. The hospital stay itself is 2–4 days; the remaining 2–3 weeks are spent recovering locally in the country to allow initial vault healing, completion of post-operative monitoring, removal of any vaginal packing or sutures (if applicable), and a formal fit-to-fly clinical assessment. For more complex cases — robotic-assisted hysterectomy with extensive adhesiolysis, concomitant major pelvic floor reconstruction, or any procedure complicated by post-operative haematoma, infection, or urinary injury — the recommended stay may extend to 4–6 weeks. Long-haul flights increase the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) in the immediate post-operative period; to mitigate this risk, GAF Healthcare's partner gynaecologists provide individualised fit-to-fly certification, and all patients are advised to wear graduated compression stockings (Class II, 23–32 mmHg), ambulate every 1–2 hours during the flight, and — where clinically indicated — self-administer low-molecular-weight heparin (e.g., enoxaparin 40 mg subcutaneously) on the day of travel.
Vaginal hysterectomy performed at high-volume gynaecological centres carries a clinical success rate of 95–98%, defined as complete, uncomplicated surgical removal of the uterus with resolution of the primary indication (e.g., cessation of abnormal uterine bleeding, correction of prolapse, elimination of fibroid-related pressure symptoms) and without major intraoperative or post-operative complications requiring unplanned re-operation or prolonged hospitalisation. Conversion to abdominal hysterectomy occurs in fewer than 2–3% of planned vaginal or laparoscopic cases at expert centres, typically due to unexpected dense adhesions, unanticipated uterine size, or intraoperative bleeding. Patient satisfaction scores consistently exceed 90% in international multicentre registry data, with the majority of women reporting significant improvement in quality of life, pelvic symptom burden, and sexual health at 12-month follow-up. The long-term durability of vaginal vault support — assessed at 5 years — exceeds 92% when McCall culdoplasty or uterosacral ligament vault suspension is performed concurrently. At GAF Healthcare's partner hospitals, outcomes are tracked through structured post-operative follow-up programmes, and surgeons selected for our network are required to demonstrate minimum annual case volumes consistent with high-volume surgical standards (typically >50 vaginal or laparoscopic hysterectomies per year per surgeon).
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides comprehensive end-to-end medical travel coordination for all international patients undergoing vaginal hysterectomy in India or the UAE, covering every non-clinical aspect of the journey.
INDIA — VISA AND ENTRY: GAF Healthcare assists patients in applying for the Indian e-Medical Visa (e-MV), which is available online to citizens of 150+ countries, is typically granted within 72 hours, allows stays of up to 60 days (extendable up to 180 days), and permits entry with one medical attendant (attendant e-Medical Visa). Our case managers provide a pre-filled visa application checklist, hospital invitation letter, and document review service to ensure approval without delays.
UAE — VISA AND ENTRY: Citizens of GCC countries, EU/UK, USA, Canada, Australia, and many Asian nations receive visa-on-arrival or visa-free entry to the UAE for 30–90 days. Citizens of other countries requiring advance visas can apply through the UAE's Federal Authority for Identity and Citizenship (ICA) online portal; GAF Healthcare provides the hospital treatment confirmation letter required to support medical visa applications through the Dubai Health Authority (DHA) or Abu Dhabi Department of Health (DoH) portals.
AIRPORT TRANSFERS: Private, air-conditioned vehicle transfers are arranged for all arrival and departure journeys, including post-operative return to the airport. Wheelchair-accessible vehicles are available on request.
HOSPITAL AND CLINICAL COORDINATION: GAF Healthcare assigns a dedicated patient case manager who liaises directly with the treating gynaecologist and hospital admissions team. This includes scheduling all pre-operative investigations, surgical booking, anaesthesia pre-assessment appointments, and post-operative follow-up consultations.
TRANSLATION AND INTERPRETATION: Professional medical interpreters are available in Arabic, Russian, French, Swahili, Bengali, Tagalog, and other major languages. Simultaneous interpretation during clinical consultations and written translation of discharge summaries, operative notes, and histopathology reports are provided.
ACCOMMODATION FOR PATIENTS AND ATTENDANTS: GAF Healthcare has negotiated preferred rates at partner serviced apartments, guesthouses, and hotels adjacent to all affiliated hospitals in Delhi, Mumbai, Chennai, Bengaluru, Dubai, and Abu Dhabi. Attendant accommodation options include rooms within the hospital (attendant cot facility at no additional charge at select hospitals) or nearby serviced apartments priced from USD 30–80 per night in India and USD 80–180 per night in the UAE.
TELEMEDICINE AND POST-DISCHARGE SUPPORT: Following discharge and return to the home country, GAF Healthcare facilitates scheduled telemedicine follow-up appointments with the treating surgeon at 2 weeks, 6 weeks, and 3 months post-operatively. Digital copies of all medical records, imaging, operative reports, and discharge summaries are securely delivered to the patient and their home-country physician.